Acute Acalculous Cholecystitis Mimicry: Symptomatic Hepatic Infiltration From Chronic Lymphocytic Leukemia Presenting
Akram Alnounou1, Henry Zou1, Harry Boamah1
1Department of Internal Medicine, Western Michigan University Homer Stryker M.D. School of Medicine, Kalamazoo, MI.
Insights
Chronic lymphocytic leukemia (CLL) rarely causes liver issues. This case highlights symptomatic cholestatic liver injury from CLL infiltration, emphasizing early diagnosis via liver biopsy for effective treatment.
Area of Science:
- Hematology
- Hepatology
- Oncology
Background:
- Chronic lymphocytic leukemia (CLL) is the most common leukemia in US adults.
- Hepatic infiltration by CLL is uncommon and can be challenging to diagnose.
- Symptomatic liver complications from CLL, such as cholestatic injury, are rare.
Abstract:
Chronic lymphocytic leukemia (CLL) is the most common adult leukemia in the United States. CLL can infiltrate the liver parenchyma or sinusoids, rarely causing symptomatic hepatic outflow obstruction or acute liver failure, making such complications difficult to recognize. We describe a patient with symptomatic, nonobstructive cholestatic liver injury due to CLL infiltration. A 53-year-old man with CLL diagnosed 4 years prior (Rai stage 0 at diagnosis), managed with observation, presented with 10 days of fever, nausea, vomiting, and diarrhea. Examination was significant for fever (39°C) and right upper quadrant tenderness with no hepatomegaly appreciated on palpation. Laboratory testing demonstrated leukocytosis and a cholestatic-predominant liver injury. Imaging demonstrated gallbladder wall thickening, splenomegaly with diffuse lymphadenopathy, a normal-appearing liver, and no biliary obstruction. Empiric antibiotics did not result in clinical improvement. The hospital course was complicated by worsening leukocytosis and elevation in inflammatory markers. Liver biopsy demonstrated portal and sinusoidal infiltration by small mature lymphocytes, consistent with CLL infiltration. The patient was discharged on hospital day 8 after biochemical and clinical improvement with pulse-dose dexamethasone. Allopurinol was initiated for tumor lysis prophylaxis. Combination therapy with obinutuzumab and venetoclax was initiated for Rai stage III CLL. Symptomatic manifestations of CLL-induced hepatic infiltration are extremely rare. In patients with cholestatic-predominant liver injury and negative biliary imaging, particularly with known CLL or unexplained splenomegaly/adenopathy, malignant hepatic infiltration should be considered early, and liver biopsy can be diagnostic and expedite definitive therapy.
Related Concept Videos
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Acute Pancreatitis II: Clinical Manifestations and Management
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Chronic Pancreatitis II: Collaborative Care
Assessment:

